BELLEVUE GROUP AG – BioMarin Pharmaceutical Inc. Transaction History
BELLEVUE GROUP AG portfolio value:
$4.53M
portfolio value
BELLEVUE GROUP AG quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -27.47% | -20.26K shares | -1.57M | $84.77 | 53.49K |
| Q2 2022 | share | Decrease | -1.14% | -847 shares | 360K | $82.87 | 73.75K |
| Q1 2022 | share | Increase | +4.48% | 3.2K shares | -556K | $77.1 | 74.6K |
| Q4 2021 | share | Increase | +38.10% | 19.7K shares | 2.31M | $89.08 | 71.4K |
| Q3 2021 | share | Increase | +27.65% | 11.2K shares | 617K | $77.29 | 51.7K |
| Q2 2021 | share | Increase | +9.46% | 3.5K shares | 585K | $83.44 | 40.5K |
| Q1 2021 | share | Increase | 0.00% | 37K shares | 2.79M | $75.51 | 37K |
| Q3 2020 | share | Decrease | -100.00% | -76.9K shares | -9.48M | $76.08 | 0 |
| Q2 2020 | share | Increase | +6.66% | 4.8K shares | 3.39M | $123.34 | 76.9K |
| Q1 2020 | share | Increase | +7.29% | 4.9K shares | 410K | $84.5 | 72.1K |
| Q4 2019 | share | Increase | 0.00% | 67.2K shares | 5.68M | $84.55 | 67.2K |
| Q1 2019 | share | Decrease | -100.00% | -45.96K shares | -3.91M | $88.83 | 0 |
| Q4 2018 | share | Decrease | -3.97% | -1.9K shares | -728K | $85.15 | 45.96K |
| Q3 2018 | share | Decrease | -3.33% | -1.65K shares | -23K | $96.97 | 47.86K |
| Q2 2018 | share | Increase | +11.66% | 5.16K shares | 1.07M | $94.2 | 49.51K |
| Q1 2018 | share | Decrease | -1.55% | -700 shares | -422K | $81.07 | 44.35K |
| Q4 2017 | share | Decrease | -7.68% | -3.75K shares | -525K | $89.17 | 45.05K |
| Q3 2017 | share | Decrease | -24.92% | -16.2K shares | -1.36M | $93.07 | 48.8K |
| Q2 2017 | share | 0.00% | 0 shares | 197K | $90.82 | 65K | |
| Q1 2017 | share | 0.00% | 0 shares | 321K | $87.78 | 65K | |
| Q4 2016 | share | 0.00% | 0 shares | -629K | $82.84 | 65K | |
| Q3 2016 | share | 0.00% | 0 shares | 957K | $92.52 | 65K | |
| Q2 2016 | share | 0.00% | 0 shares | -304K | $77.8 | 65K | |
| Q1 2016 | share | Increase | 0.00% | 65K shares | 5.36M | $82.48 | 65K |